173 related articles for article (PubMed ID: 22178210)
1. Myc target miRs and liver cancer: small molecules to get Myc sick.
Buendia MA; Bourre L; Cairo S
Gastroenterology; 2012 Feb; 142(2):214-8. PubMed ID: 22178210
[No Abstract] [Full Text] [Related]
2. c-myc overexpression in hepatocarcinogenesis.
Feitelson MA
Hum Pathol; 2004 Nov; 35(11):1299-302. PubMed ID: 15668885
[No Abstract] [Full Text] [Related]
3. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
4. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.
Shachaf CM; Kopelman AM; Arvanitis C; Karlsson A; Beer S; Mandl S; Bachmann MH; Borowsky AD; Ruebner B; Cardiff RD; Yang Q; Bishop JM; Contag CH; Felsher DW
Nature; 2004 Oct; 431(7012):1112-7. PubMed ID: 15475948
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
6. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
Yang S; Wang M; You W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
[TBL] [Abstract][Full Text] [Related]
8. Signature genes for both hepatoblastoma and hepatocellular carcinoma.
Chen F; Li S; Castranova V
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1220-2. PubMed ID: 19749507
[No Abstract] [Full Text] [Related]
9. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
10. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
12. Molecular biological diagnosis and gene therapy of hepatocellular carcinoma: the present status.
Ji JF
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):724-5. PubMed ID: 12914006
[No Abstract] [Full Text] [Related]
13. Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme.
Cheng J; Luo J; Zhang X; Hu J; Hui H; Wang C; Stern A
Cancer Gene Ther; 2000 Mar; 7(3):407-12. PubMed ID: 10766346
[TBL] [Abstract][Full Text] [Related]
14. [Oncogene c-myc].
Tsujiuchi T; Nakae D; Konishi Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():116-20. PubMed ID: 11761924
[No Abstract] [Full Text] [Related]
15. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
16. Antisense regulation of expression and transactivation functions of the tumorigenic HBx and c-myc genes.
Hung L; Kumar V
Biochem Biophys Res Commun; 2006 May; 344(1):293-9. PubMed ID: 16616001
[TBL] [Abstract][Full Text] [Related]
17. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
Shirahata A; Fan W; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2011 Mar; 31(3):777-80. PubMed ID: 21498695
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures and prognosis of hepatocellular carcinoma.
Hoshida Y
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma.
Law PT; Wong N
J Gastroenterol Hepatol; 2011 Mar; 26(3):437-49. PubMed ID: 21332540
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
